Dishman Carbogen Amcis Limited - ROE
DCAL.NS
Price:
$167.25
Market Cap:
$26.22B
Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen Amcis Limited provides specialized contract research and manufacturing solutions to the worldwide pharmaceutical sector. The company operates through two main business segments: Contract Research and Manufacturing Services (CR&MS), and Marketable Molecules. Beyond its core services, it manufactures and distributes an extensive portfolio of products, including bulk drugs, chemical intermediates, various phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D derivatives, and fine chemicals. Additionally, its offerings encompass personal care products like hand and body washes,...[Read more]
Industry
Biotechnology
IPO Date
2004-04-22
Stock Exchange
NSE
Ticker
DCAL.NS
The ROE as of September 2026 (TTM) for Dishman Carbogen Amcis Limited (DCAL.NS) is 1.05%
According to Dishman Carbogen Amcis Limited’s latest financial reports and current stock price. The company's current ROE is 1.05%. This represents a change of 294.74% compared to the average of 0.27% of the last 4 quarters.
Dishman Carbogen Amcis Limited (DCAL.NS) Historical ROE (quarterly & annually)
How has DCAL.NS ROE performed in the past?
The mean historical ROE of Dishman Carbogen Amcis Limited over the last ten years is 0.84%. The current 1.05% ROE has changed 24.11% with respect to the historical average. Over the past ten years (40 quarters), DCAL.NS's ROE was at its highest in in the September 2016 quarter at 2.28%. The ROE was at its lowest in in the March 2021 quarter at -2.37%.
Average
0.84%
Median
0.89%
Minimum
-2.90%
Maximum
3.91%
Dishman Carbogen Amcis Limited (DCAL.NS) ROE by Quarter and Year
Discovering the peaks and valleys of Dishman Carbogen Amcis Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.53%
Maximum Annual ROE = 3.91%
Minimum Annual Increase = -258.04%
Minimum Annual ROE = -2.90%
| Year | ROE | Change |
|---|---|---|
| 2026 | 1.46% | 2.53% |
| 2025 | 0.06% | -102.04% |
| 2024 | -2.73% | 431.60% |
| 2023 | -0.51% | -258.04% |
| 2022 | 0.32% | -111.20% |
| 2021 | -2.90% | -204.49% |
| 2020 | 2.77% | -29.08% |
| 2019 | 3.91% | 29.20% |
| 2018 | 3.03% | 0.18% |
| 2017 | 3.02% | -74.37% |
Dishman Carbogen Amcis Limited (DCAL.NS) Average ROE
How has DCAL.NS ROE performed in the past?
The current ROE of Dishman Carbogen Amcis Limited (DCAL.NS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.40%
5-year avg
-0.28%
10-year avg
0.84%
Dishman Carbogen Amcis Limited (DCAL.NS) ROE vs. Peers
How is DCAL.NS’s ROE compared to its peers?
Dishman Carbogen Amcis Limited’s ROE is greater than Zota Health Care Limited (-20.39%), less than Innova Captab Limited (14.59%), less than Aarti Drugs Limited (13.06%), less than Aarti Drugs Limited (13.06%), less than Sun Pharma Advanced Research Company Limited (318.71%), less than Sun Pharma Advanced Research Company Limited (318.71%), greater than Suven Life Sciences Limited (-111.54%), greater than Suven Life Sciences Limited (-111.54%), less than Supriya Lifescience Ltd (17.40%), less than Supriya Lifescience Limited (17.40%),
| Company | ROE | Market cap |
|---|---|---|
| -20.39% | $32.98B | |
| 14.59% | $65.65B | |
| 13.06% | $39.11B | |
| 13.06% | $39.11B | |
| 318.71% | $63.61B | |
| 318.71% | $63.50B | |
| -111.54% | $81.08B | |
| -111.54% | $79.97B | |
| 17.40% | $72.74B | |
| 17.40% | $72.58B |
Build a custom stock screener for Dishman Carbogen Amcis Limited (DCAL.NS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dishman Carbogen Amcis Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Dishman Carbogen Amcis Limited (DCAL.NS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Dishman Carbogen Amcis Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Dishman Carbogen Amcis Limited's ROE?
How is the ROE calculated for Dishman Carbogen Amcis Limited (DCAL.NS)?
What is the highest ROE for Dishman Carbogen Amcis Limited (DCAL.NS)?
What is the 3-year average ROE for Dishman Carbogen Amcis Limited (DCAL.NS)?
What is the 5-year average ROE for Dishman Carbogen Amcis Limited (DCAL.NS)?
How does the current ROE for Dishman Carbogen Amcis Limited (DCAL.NS) compare to its historical average?